Defined, serum-free conditions for in vitro culture of primary human T-ALL blasts

Leukemia

Volumn 27, Issue 6, 2013, Pages 1437-1440

  Yost, A J ^a   Shevchuk, O O ^a   Gooch, R ^b   Gusscott, S ^a   You, M J ^c   Ince, T A ^d   Aster, J C ^b   Weng, A P ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 6; LAMININ; RECOMBINANT STEM CELL FACTOR; SCATTER FACTOR; SOMATOMEDIN C; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; EX VIVO STUDY; GROWTH CURVE; HETERODUPLEX ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LETTER; LONG TERM SURVIVAL; PERSONALIZED MEDICINE; PRIORITY JOURNAL; SURVIVAL RATE; T LYMPHOBLAST;

CULTURE MEDIA; CULTURE MEDIA, SERUM-FREE; HUMANS; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84878932776     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.337     Document Type: Letter

References (15)

1. Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2008; 111: 1827-1833. (Pubitemid 351451489)
2. Armstrong F, Brunet de la Grange P, Gerby B, Rouyez MC, Calvo J, Fontenay M et al. NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity. Blood 2009; 113: 1730-1740.
3. Chiu PP, Jiang H, Dick JE. Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance. Blood 2010; 116: 5268-5279.
4. Cox CV, Martin HM, Kearns PR, Virgo P, Evely RS, Blair A. Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia. Blood 2007; 109: 674-682. (Pubitemid 46105969)
5. Aster JC, Pear WS, Blacklow SC. Notch Signaling in Leukemia. Annu Rev Pathol 2008; 3: 587-613. (Pubitemid 351488294)
6. Medyouf H, Gao X, Armstrong F, Gusscott S, Liu Q, Larson Gedman A et al. Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss. Blood 2010; 115: 1175-1184.
7. Medyouf H, Gusscott S, Wang H, Tseng JC, Wai C, Nemirovsky O et al. High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling. J Exp Med 2011; 208: 1809-1822.
8. Ince TA, Richardson AL, Bell GW, Saitoh M, Godar S, Karnoub AE et al. Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell 2007; 12: 160-170. (Pubitemid 47199120)
9. Barata J, Cardoso A, Boussiotis V. Interleukin-7 in T-cell acute lymphoblastic leukemia: An extrinsic factor supporting leukemogenesis? Leuk Lymphoma 2005; 46: 483-495. (Pubitemid 40584864)
10. Lacy MQ, Alsina M, Fonseca R, Paccagnella ML, Melvin CL, Yin D et al. Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor Type 1 receptor monoclonal antibody Cp-751,871 in patients with multiple myeloma. J Clin Oncol 2008; 26: 3196-3203JCO.2007.2015.9319.
11. Kurtzhals P, Schaffer L, Sørensen A, Kristensen C, Jonassen I, Schmid C et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000; 49: 999-1005. (Pubitemid 30349423)
12. Soos MA, Field CE, Siddle K. Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem J 1993; 290(Pt 2): 419-426. (Pubitemid 23094937)
13. Suzuki J, Fujita J, Taniguchi S, Sugimoto K, Mori KJ. Characterization of murine hemopoietic-supportive (MS-1 and MS-5) and non-supportive (MS-K) cell lines. Leukemia 1992; 6: 452-458.
14. Dallas MH, Varnum-Finney B, Martin PJ, Bernstein ID. Enhanced T-cell reconstitution by hematopoietic progenitors expanded ex vivo using the Notch ligand Delta1. Blood 2007; 109: 3579-3587. (Pubitemid 46572553)
15. Gerby B, Armstrong F, de la Grange PB, Medyouf H, Calvo J, Verhoeyen E et al. Optimized gene transfer into human primary leukemic T cell with NOD-SCID/leukemia-initiating cell activity. Leukemia 2010; 24: 646-649.